Hims & Hers' Dr. Craig Primack explains why personalized care, not just GLP-1s, is the key to lasting weight loss success.
Novo Nordisk ends its Wegovy deal with Hims & Hers, citing safety concerns as the telehealth firm pushes back.
Hims & Hers is acquiring European digital health firm Zava in an all-cash deal, marking its expansion into Germany, France and Ireland.
Hims & Hers and Novo Nordisk are teaming to expand affordable access to weight loss treatments, launching a bundled Wegovy offering.
The health and wellness platform has acquired a U.S.-based peptide facility to support its personalized care offerings.
The health and wellness platform has acquired a NJ-based lab testing facility that will support its whole-body testing ambitions.
Athletech News has rounded up the top Super Bowl ads that are changing the conversation on health, wellness and female athleticism.
A new report from Hims & Hers underscores the urgency of weight loss for Americans as companies race to distribute weight loss medications.
Hims & Hers has added protein-packed meal replacement bars and shakes for GLP-1 users and those focused on weight management.
Hims & Hers has released a white paper showing that 87% of its GLP-1 weight loss program customers are close to their goal or have met it.
Sign Up to Our Newsletter
